TNF Pharmaceuticals (TNFA)
NASDAQ:TNFA
Holding TNFA?
Track your performance easily

TNF Pharmaceuticals (TNFA) Financial Statements

534 Followers

TNF Pharmaceuticals Financial Overview

TNF Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-10.693; its P/E ratio is -0.12; TNF Pharmaceuticals is scheduled to report earnings on May 20, 2019, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -9.57M$ 2.77M$ -3.84M$ -4.17M$ -1.51M
EBITDA$ -9.57M$ 2.77M$ -3.84M$ -4.17M$ -1.51M
Net Income Common Stockholders$ -10.34M$ -11.00M$ 2.88M$ -4.54M$ -97.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 13.07M$ 1.74M$ 8.47M$ 11.63M$ 15.55M
Total Assets$ 26.38M$ 14.49M$ 21.83M$ 25.25M$ 28.41M
Total Debt$ 25.80K$ 35.98K$ 72.63K$ 109.79K$ 126.03K
Net Debt$ -13.04M$ -1.70M$ -8.40M$ -11.52M$ -15.42M
Total Liabilities$ 26.00M$ 4.25M$ 5.72M$ 14.48M$ 14.40M
Stockholders Equity$ 97.81K$ 9.94M$ 15.50M$ 10.74M$ 13.09M
Cash Flow-
Free Cash Flow$ -2.67M$ -1.91M$ -3.16M$ -3.92M$ -3.97M
Operating Cash Flow$ -2.67M$ -1.91M$ -3.16M$ -3.92M$ -3.97M
Investing Cash Flow$ -11.02M$ 732.02K$ 3.36M$ 3.83M$ -11.27M
Financing Cash Flow$ 14.00M$ -1.28M--$ 14.69M
Currency in USD

TNF Pharmaceuticals Earnings and Revenue History

TNF Pharmaceuticals Debt to Assets

TNF Pharmaceuticals Cash Flow

TNF Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis